AKT1 and acute lymphoblastic leukemia: The PI3K/Akt signaling pathway is frequently constitutively activated in T-ALL, mainly due to PTEN inactivating mutations [60,61], which is coherent with PTEN mutations documented in the analyzed T-ALL cell lines [54].